Picture of Nascent Biotech logo

NBIO Nascent Biotech Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Nascent Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments0.1310.0030.0010.0940.172
Net Total Accounts Receivable
Net Total Receivables0.750
Prepaid Expenses
Total Current Assets0.1310.0030.7510.1050.255
Total Assets0.1310.0030.7510.1050.255
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.6142.881.220.7771.55
Total Long Term Debt
Total Debt
Total Liabilities0.6142.881.220.7771.55
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-0.482-2.88-0.473-0.671-1.3
Total Liabilities & Shareholders' Equity0.1310.0030.7510.1050.255
Total Common Shares Outstanding
Total Preferred Shares Outstanding